Undifferentiated sinonasal carcinoma may respond to single-fraction boron neutron capture therapy.
A large, rapidly progressing, unresectable undifferentiated sinonasal head and neck carcinoma regressed rapidly following single fraction boron neutron capture therapy (BNCT). The main toxicity consisted of mucositis lasting for a few days. The quality of life improved and was excellent until tumour recurrence 6 months after the date of BNCT.
Kouri
Mauri
M
Department of Laboratory Diagnostics, Helsinki University Central Hospital, P.O. Box 180, FIN-00029 HUCH, Finland.
Kankaanranta
Leena
L
Seppälä
Tiina
T
Tervo
Leena
L
Rasilainen
Merja
M
Minn
Heikki
H
Eskola
Olli
O
Vähätalo
Jyrki
J
Paetau
Anders
A
Savolainen
Sauli
S
Auterinen
Iiro
I
Jääskeläinen
Juha
J
Joensuu
Heikki
H
D000328:Adult; D016754:Boron Neutron Capture Therapy; D002277:Carcinoma / Q000532:radiotherapy*; D006801:Humans; D008297:Male; D009092:Mucous Membrane / Q000473:pathology; D010255:Paranasal Sinus Neoplasms / Q000532:radiotherapy*; D011788:Quality of Life; D013280:Stomatitis / Q000209:etiology; D016896:Treatment Outcome